Development of tertiary hyperparathyroidism after long term phosphate supplementation in hypophoshatemic osteomalacia;Hyperparathyroidie tertiaire induite par le traitement d'une osteomalacie hypophosphoremique

Annales d'Endocrinologie

Volumn 57, Issue 3, 1996, Pages 215-218

  Vedere, V ^a   Goupille, P ^a   Valat, J P ^a   Lecomte, P ^b  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

osteomalacia; phosphorus; tertiary hyperparathyroidism

Indexed keywords

CALCITRIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS;

ADULT; ARTICLE; CASE REPORT; HUMAN; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA; MALE; OSTEOMALACIA; BLOOD; CHEMICALLY INDUCED DISORDER;

ADULT; HUMANS; HYPERPARATHYROIDISM; MALE; OSTEOMALACIA; PHOSPHORUS;

EID: 0029744372     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. BALSAN S, TIEDER M. Linear growth in patients with hypophosphatemic familial rickets , influence of treatment regimen and parental height. J Pediatr 1990 , 116 : 365-71
2. BETTINELL A, BIACHI ML, MAZZUCCHI E, GANDOLIN G, APPOANI AC. Acute effects of calcitriol and phosphate salts on mineral metabolism in children with hypophosphatemic rickets. J Pediatr 1991 ; 118 : 372-6.
3. BROWN AJ, RITTER CR, FINCH JL. The non calcemic analogue of vitamine D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. J Clin Invest 1989 ; 84 : 728-32.
4. FALLS WF, CARTER NW, RECTOR Jr FC, SELDIN DW. Familial hypophosphatemic rickets. Study of six cases with evaluation of the pathogenic role of secondary hyperparathyroidism. Ann Intern Med 1968 ; 68 : 553-60.
5. FIRTH RG, GRANT CS, RIGGS BL. Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Am J Med 1985 ; 78 : 669-73.
6. GLANVILLE HJ, BLOOM R Case of renal tubular osteomalacia (Dent type 2) with later development of autonomous parathyroid tumors. Br Med J 1965 ; 2 : 26-9
7. GLORIEUX FH, MARIE PJ, PETTIFOR JM, DELVIN EE. Bone response to phosphate salts, ergocalciferol and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 1980 ; 303 : 1023-31.
8. GLORIEUX FH, SCRIVER CR, READE TM, GOLDMAN H, ROSEBOROUGH A. Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia. N Engl J Med 1972 ; 287 : 481-7.
9. HEBERT LA, LEMANN J, PETERSEN JR, LENNON EJ Studies of the mechanism by which phosphate infusion lowers serum calcium concentration J Clin Invest 1966 ; 45 : 1886-94.
10. KLEEREKOPER M, COFFEY R, GRECO T. Hypercalcemic hyperparathyroidism in hypophosphatemic rickets. J Clin Endocrinol Metab 1977 ; 45 : 86-94.
11. RASMUSSEN H, PECHET M, ANAST C, MAZUR A, GERTNER J, BROADUS AE. Long-term treatment of familial hypophosphatemic rickets with oral phosphate and 1-alpha-hydroxy vitamin D-3. J Pediatr 1981 ; 99 : 16-25.
12. REISS E, CANTERBURY JM, BERCOVITZ MA, KAPLAN EL. The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest 1970 ; 49 : 2146-9.
13. REITZ RE, WEINSTEIN RL. Parathyroid hormone secretion in familial vitamin D-resistant hypophosphatemia. Science 1971 ; 173 : 845-7.
14. RIVKEES SA, EL-HAJJ-FULEIHAN G, BROWN EM, CRAWFORD JD Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. J Clin Endocrinol Metab 1992 , 75 : 1514-8.
15. TALWALKAR YB, MUSGRAVE JE, BUIST NRM, CAMPBELL RA, CAMPBELL JR. Vitamin D-resistant rickets and parathyroid adenomas. Am J Dis Child 1974 ; 128 : 704-8
16. THOMAS WC, FRY RM. Parathyroid adenomas in chronic rickets. Am J Med 1970 ; 49 : 404-7.